| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |